CORPORATE WEIGHT HEALTH

Bodyline provides weight health programmes combining gold standard support and the latest GLP-1 weight loss injections

CORPORATE weight HEALTH

Bodyline provides weight health programmes combining gold standard support and the latest GLP-1 weight loss injections​

Bodyline is a leading UK provider of clinically supported weight health programmes.  With over 17 years of experience, we recognise that weight management has a huge impact on a person’s health and plays a crucial role in maintaining overall well-being.  Weight has a significant effect on various aspects of well-being ranging from physical, emotional, social to mental health. 

For a growing proportion of the UK population, controlling and managing weight can be incredibly difficult, especially when diet and exercise alone doesn’t appear to be having a positive effect. For those individuals who are struggling with weight gain, medical weight loss treatments and clinical support yield positive weight loss results.

Obesity is a challenging, complex, and controversial public health issue and is increasingly having negative consequences in the workplace. As a result, weight health at work is on many business’ agenda.  Healthy weight employees improve wellbeing in the workplace, reduce costs and risks to the organisation, as well as prevent weight related illnesses.

One of the most effective ways to optimise workplace weight health is to commit to a corporate wellness solution that includes support plans, effective medical treatment and individual pathways based on the specific weight health needs. Partnering with a clinical weight loss and medical wellness service provider such as Bodyline, provides an opportunity to implement better occupational health strategies, gold standard treatment and workforce support throughout an organisation. 

The increased availability of the ‘game changing’ NICE approve GLP-1 weight loss injections supports effective and safe treatment for those that are overweight or struggling with obesity.  These, prescription only, weight loss injections are called GLP-1 (glucagon-like peptide-1) receptor agonists and are marketed for obesity under the brand names Wegovy (semaglutide) and Saxenda (liraglutide).  GLP-1 is a hormone that is naturally produced in the intestines upon finishing a meal, signalling to the brain that the meal is finished and promoting the feeling of fullness. GLP-1 plays a role in regulating blood sugar levels and appetite. When mimicked with the help of weight loss injections, users consume less food, therefore less calories, allowing them to lose weight much easier and change their association with food.  Mounjaro (tirepatide) will be the next weight loss injection to be launched in the UK.  It will be the first approved combined glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 glucagon-like peptide-1 and has been clinically found to be more effective with weight loss results. 

Bodyline has a UK wide scalable weight loss treatment infrastructure and access to a robust medication supply chain to support collaboration with partners such as employers, occupational health professionals, health insurance as well as other complementary weight health providers.  We have success in providing gold standard clinical interventions and specialist support to reduce obesity in society and in the workplace.     

Key Weight Health Facts

UK ranked 4th in Europe for overweight & obesity
15 million people in UK obese
26 million people in UK will be obese by 2030
Obesity levels in UK tripled in last 30 years
¾ of population aged 45-74 are overweight or obese
68% of men are overweight or obese
60% of women are obese or overweight
Medical cost increases between £1.9 - £2 billion per year for obesity related diseases by 2030
31% of adults feel judged at work due to obesity
Obese employees have 4 extra days sick per year
37 million UK sick days due to obesity

BODYLINE WEIGHT HEALTH CORPORATE JOURNEY

Step One:
MAKE AN APPOINTMENT WITH OUR CORPORATE PARTNERSHIP WEIGHT HEALTH TEAM

Contact our weight health customer services team to find out more about our corporate weight health solutions.
Book a meeting with our corporate partnership weight health team here.

Step Two:
CORPORATE PARTNERSHIPS WEIGHT HEALTH TEAM MEETING TO DISCUSS BODYLINE WEIGHT HEALTH OPTIONS

Our corporate partnership weight health team will meet with you and provide an overview of Bodyline’s weight health options and define scope for collaboration.

Step Three:
BODYLINE’S CORPORATE WEIGHT HEALTH PROPOSAL ALIGNED WITH YOUR ORGANISATIONAL REQUIREMENTS

Bodyline’s weight health corporate solution starts with a business audit or scoping session to understand how obesity is being managed currently and what if any clinical treatment and support is in place. We also gain an understanding of the risks of weight health to your clients or employees. From this information a tailored weight health collaboration proposal will be defined with deliverables, a detailed patient journey proposed, and when agreed, a contract signed off.

Step Four:
BODYLINE COLLABORATIVE WEIGHT HEALTH PROGRAMME LAUNCH AND ENGAGEMENT

Bodyline supports the launch of Bodyline's medical weight health programme within your organisation and if required support with creating awareness within your client base. Activities can include amongst others training and education and generating wider market engagement through joint marketing.

Step Five:
BODYLINE WEIGHT HEALTH PROGRAMME ROLL OUT

At a patient level our specialist medical weight loss nurses engage and carry out a complete triage onboarding process. The aim of this process is to identify if medical weight loss is suitable for the patient and if so, which medication should be prescribed alongside a personalised holistic treatment plan.

Step Six:
CONTINUED PATIENT SUPPORT AND BODYLINE WEIGHT HEALTH DELIVERABLE REVIEW

Bodyline understand the value of a personalised supported patient weight loss journey and that extra support and medication dose changes will be required to reach weight loss goals.

Bodyline will also have agreed review meetings with the organisation based on what was outlined in the corporate weight loss programme plan. As the programme evolves, the plan will be refined to ensure deliverable and guarantee business relevance.

WEIGHT HEALTH EFFECTS ON PEOPLE IN THE WORKPLACE

Invest in treating and supporting weight health and improve your business performance

OBESITY HEALTH RISKS

Business costs

bodyline works. Bodyline cares.

Collaborative & tailored

Safe &
qualified

Personalised & supported

Corporate health news and views

Weight loss has never been an easy feat, particularly when factors outside of your control are impacting your ability to lose weight effectively or sustainably with diet and exercise alone. Genetics, metabolism, and hormonal imbalances can all have negative effects on weight and make it incredibly hard to get the weight off without sufficient support.
In March 2023, the World Obesity Federation released their projections for the weight health of the world’s population. Their current estimates see more than half of the world’s population, that is over 4 billion people, will be obese by 2035 if the world continues the same trends.
In today's society, weight discrimination remains a prevalent issue that affects individuals in various settings, including the workplace. In fact, more than two thirds of employees in the UK see it happen in their workplace, with 47% believing it to be a serious problem. The stigma of obesity is disproportionate considering its status as a disease that is often difficult to overcome with just diet and exercise alone.

CONTACT US TODAY

Find out more about collaboration opportunities with Bodyline to support weight health.

"*" indicates required fields

By submitting this form you agree to the Bodyline privacy policy.